Federal Pharmacy Law Basics for Pharmacy Technicians
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Federal pharmacy law can look like a wall of numbers: five schedules, several DEA forms, refill caps and record-keeping periods. Most of it comes from the Controlled Substances Act (CSA) and its regulations in 21 CFR Parts 1300–1321, enforced by the Drug Enforcement Administration (DEA). This guide covers the federal baseline. Your state board of pharmacy can, and often does, add stricter rules.
The five schedules
Drugs are scheduled by accepted medical use and potential for abuse and dependence. One ingredient can sit in several schedules depending on form and strength; codeine is the classic example.
| Schedule | What it means | Examples |
|---|---|---|
| I | High abuse potential, no currently accepted medical use | heroin, LSD |
| II | High abuse potential; accepted medical use (sometimes with severe restrictions); abuse may lead to severe psychological or physical dependence | oxycodone, fentanyl, methadone, methylphenidate, hydrocodone combination products |
| III | Less abuse potential than I and II; abuse may lead to moderate or low physical dependence or high psychological dependence | ketamine, anabolic steroids such as testosterone, acetaminophen with codeine tablets |
| IV | Lower abuse potential and dependence risk than III | alprazolam, diazepam, lorazepam, zolpidem, tramadol, carisoprodol |
| V | Lower abuse potential than IV; limited amounts of certain narcotics | codeine cough preparations with not more than 200 mg per 100 mL, pregabalin, diphenoxylate with atropine |
Since April 28, 2026, marijuana in an FDA-approved drug product, or under a state medical marijuana license, is in Schedule III; all other marijuana remains in Schedule I.
DEA registration and the forms a pharmacy uses
A pharmacy needs a DEA registration for its location before handling controlled substances. Applications and renewals are filed online.
| Form | Used for | Key federal timing |
|---|---|---|
| 224 | New retail pharmacy registration | Registration lasts 3 years; renew on 224a |
| 222 | Ordering Schedule I and II drugs on paper | Single-sheet form; the original goes to the supplier and the pharmacy keeps its copy of each executed form for 2 years |
| CSOS | Electronic equivalent of the 222 | Optional; records kept 2 years |
| 106 | Reporting theft or significant loss | Written notice to DEA within 1 business day of discovery; Form 106 within 45 days |
| 41 | Recording controlled substances destroyed | Kept as a record for 2 years; sent to DEA only if requested |
- The triplicate 222 was replaced by a single-sheet form; DEA stopped accepting triplicates in October 2021.
- CSOS (Controlled Substance Ordering System) uses DEA-issued digital certificates instead of paper.
- The one-business-day notice and the electronic Form 106 are two separate steps.
- A Form 41 record carries the signatures of two employees who witnessed the destruction. Drugs sent to a reverse distributor are recorded as transfers instead.
Prescriptions, refills, transfers and partial fills
What the prescription must include
Under 21 CFR 1306.05, a controlled substance prescription must be dated and signed on the day it is issued and show:
- the patient's full name and address
- the prescriber's name, address and DEA registration number
- drug name, strength, dosage form and quantity
- directions for use
Paper prescriptions must be manually signed; electronic ones must come from software meeting DEA's rules in Part 1311. In an emergency a prescriber may phone in a Schedule II prescription for the emergency quantity, then must deliver a written prescription within 7 days.
Telemedicine: under a temporary DEA and HHS rule (21 CFR 1307.41), a DEA-registered prescriber may issue Schedule II–V prescriptions after a telemedicine visit without first seeing the patient in person, but only through December 31, 2026; check DEA (the Diversion Control website or 21 CFR 1307.41 on eCFR) for any extension or replacement, and follow your state's rules, which can be stricter.
Refill limits
Schedule II: no refills. A prescriber may instead issue several separate prescriptions covering up to a 90-day supply, each marked with the earliest date it may be filled.
Schedules III and IV: a prescription may be refilled up to 5 times, and not filled or refilled more than 6 months after the date it was issued, whichever limit is hit first.
Schedule V: federal rules do not apply the five-refill, six-month cap; refills follow the prescriber's authorization (many states add limits).
Worked example. A Schedule III prescription is issued March 1 with 5 refills. The patient picks up a refill every 45 days:
- March 1 + 45 days = April 15 (refill 1)
- April 15 + 45 = May 30 (refill 2)
- May 30 + 45 = July 14 (refill 3)
- July 14 + 45 = August 28 (refill 4)
- August 28 + 45 = October 12, which is past September 1 (six months after issue)
The fifth refill cannot be filled even though it is still on the label. The six-month limit came first.
Transfers and partial fills
- Transfers: Schedule III–V prescription information may be transferred for refills one time only, pharmacist to pharmacist. Pharmacies sharing a real-time online database may transfer up to the remaining refills. Since a 2023 DEA rule, an electronic Schedule II–V prescription may also be transferred once for its initial fill, at the patient's request, and must stay electronic.
- Schedule II partial fills: if the pharmacy cannot supply the full quantity, the rest may be supplied within 72 hours. If the patient or prescriber requests a partial fill, remaining portions must be filled within 30 days of the date written. For long-term care or terminally ill patients, partial fills may continue for up to 60 days from issue.
Inventory requirements
- Initial inventory when the pharmacy first handles controlled substances.
- Biennial inventory at least every 2 years after that.
- Schedule II: exact count of opened containers.
- Schedules III–V: an estimated count of opened containers is allowed, unless the container holds more than 1,000 tablets or capsules, which then requires an exact count.
- Inventories are kept at the registered location for 2 years.
Example: an opened 100-count bottle of a Schedule II tablet is counted exactly; an opened 500-count bottle of a Schedule IV tablet may be estimated.
CMEA and PPPA
Combat Methamphetamine Epidemic Act (CMEA)
Nonprescription products containing pseudoephedrine, ephedrine or phenylpropanolamine are "scheduled listed chemical products." Federal rules require:
- storage behind the counter or in a locked cabinet
- a written or electronic logbook (product, quantity, buyer's name and address, date and time), signed by the buyer and kept at least 2 years; a sale of a single package containing 60 mg or less of pseudoephedrine is exempt from the logbook
- photo identification from the buyer
- seller training and self-certification
- sales limits: 3.6 g per day per purchaser, a buyer limit of 9 g per 30 days, and 7.5 g per 30 days for mail-order sales
Limits are in grams of base, not the salt amount on the box. Example: if a package contains 2.4 g of pseudoephedrine base, one package is allowed in a day, but two are 2.4 + 2.4 = 4.8 g, over the 3.6 g limit.
Poison Prevention Packaging Act (PPPA)
The PPPA, administered by the Consumer Product Safety Commission, requires most oral prescription drugs to be dispensed in child-resistant packaging. Conventional (easy-open) packaging may be used when the prescriber directs it on the prescription or the purchaser asks. The regulation also lists exemptions; sublingual nitroglycerin is the classic one, because patients need quick access.
States can be stricter
Federal law is the floor; when a state rule is stricter, the pharmacy follows it. Federal transfer rules even say a transfer is allowed only if state law permits it. States commonly differ on:
- placing additional drugs in a state controlled substance schedule
- shorter time limits for filling a controlled substance prescription, or refill limits on Schedule V
- requirements to e-prescribe controlled substances
- reporting dispensing data to, and checking, a prescription drug monitoring program
- day-supply or quantity limits on opioid prescriptions
- tighter pseudoephedrine rules, or whether any Schedule V product can be sold without a prescription
- a separate state controlled substance license for the pharmacy
Always check your state board of pharmacy's rules.
Key takeaways
- The CSA sorts drugs into Schedules I–V; Schedule I has no accepted medical use.
- Know the forms: 224 (register), 222 or CSOS (order C-II), 106 (theft or loss), 41 (destruction).
- C-II: no refills. C-III and IV: 5 refills or 6 months, whichever comes first.
- Biennial inventory: exact count for C-II; estimate allowed for opened C-III–V containers of 1,000 units or fewer.
- CMEA sets daily and 30-day pseudoephedrine limits in grams of base, with a 2-year logbook.
- State law can be stricter, and then the stricter rule wins.
Quick check
Q1. A Schedule IV prescription was issued June 1 with 5 refills. On December 15 the patient asks for a refill, and 2 refills remain. Can it be filled?
Answer: No. More than six months have passed since the issue date, so the remaining refills have expired.
Q2. A pharmacy discovers a significant loss of a Schedule II drug. What are the two federal reporting steps?
Answer: Notify DEA in writing within one business day, then file DEA Form 106 within 45 days. The first step alerts DEA right away; the form allows time to investigate.
Q3. During the biennial inventory, may a technician estimate the count of an opened bottle of a Schedule II tablet?
Answer: No. Schedule II requires an exact count; estimates are allowed only for Schedules III–V.
Practice these in Pillworks Idle.
Sources
- eCFR — 21 CFR 1307.41, Telemedicine flexibilities
- eCFR — 21 CFR Part 1306, Prescriptions
- eCFR — 21 CFR 1304.11, Inventory requirements
- eCFR — 21 CFR 1301.76, Other security controls for practitioners
- eCFR — 21 CFR Part 1314, Retail Sale of Scheduled Listed Chemical Products
- eCFR — 16 CFR 1700.14, Substances requiring special packaging
- DEA Diversion Control Division — Pharmacist's Manual
- DEA — Drug Scheduling